SynthesisFrontiers in immunology2025

Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia.

Thamir A Alandijany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.